Innovative Clinical Trial Begins for Patients Diagnosed with Primary Glioma

Cleveland Clinic Taussig Cancer Center

The Tug McGraw Foundation offers this exciting news about a groundbreaking new clinical trial currently underway in conjunction with the National Cancer Institute.  This trial explores the impact of alternative and dietary interventions along with other compatible therapies in the treatment of brain tumors.
Dr. Lee Jones, the director of the Tug McGraw Research Center at the Preston Robert Tisch Brain Tumor Center at Duke University, shares our enthusiasm for this pioneering study and offers his insights on its potential:

This innovative clinical trial will begin to address many unanswered questions regarding the efficacy of dietary and complementary and alternative medicine interventions in patients diagnosed with primary glioma. Moreover, this trial will also test a specific biologic mechanism that may underlie the potential efficacy of dietary interventions on important patient outcomes such as brain edema, quality of life, and overall survival.

Overall, this trial will provide important insights into the role of lifestyle interventions in the treatment and recovery from a primary glioma diagnosis, which is currently a vastly understudied area of research.

To further explore the potential of this exciting and groundbreaking new study, please consult the National Cancer Institute by visiting their website at www.cancer.gov.